As artificial intelligence (AI) continues to reshape the medical device industry, regulatory frameworks are lagging behind the technological advancements. AI promises enhancements in patient outcomes, safety, and clinical efficiency; however, the rapid evolution of AI technologies, including predictive and generative AI, introduces significant regulatory challenges. One of the primary hurdles is the fragmented nature of...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
